Clinical Trial

Phase I Clinical Study of ZL-65 Tablet in Healthy Adult Participants in China

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
To evaluate the tolerability and safety of a single oral dose of ZL-65 tablets in healthy adult trial participants through dose escalation; and to preliminarily assess the pharmacokinetic and pharmacodynamic characteristics of a single oral dose of ZL-65 tablets.Exploring the impact of food intake on the PK of orally administered ZL-65 tablets in healthy adult trial participants.
Trial Details
NCT Number NCT07757152
Lead Sponsor Chengdu Zenitar Biomedical Technology Co., Ltd
Conditions Healthy Participants Study
Enrollment 108 participants
Start Date 2026-07-23
Primary Completion 2027-07-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-11